Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

Donate now TQ Pro - 1€/mo

In Fight Against Pancreatic Cancer, Daraxonrasib Is Rare Sign Of Hope

Posted on June 8, 2026
By Forbes
0 Views
1 min read

In Fight Against Pancreatic Cancer, Daraxonrasib Is Rare Sign Of Hope

The death rate in the group treated with daraxonrasib was 60% lower than those on chemotherapy. This is hailed as a major advance against metastatic pancreatic cancer.